Abstract
Introduction

Although intravenous immunoglobulin (IVIg) is considered to be a first-line treatment for autoimmune neuropathy, such as Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyradiculneuropathy (CIDP), and multifocal motor neuropathy (MMN) (1), there is still a reluctance to use IVIg in cases of atypical neuropathy. IgM monoclonal gammopathy has been reported to be involved in various peripheral neuropathies
, there are few reports about peripheral neuropathy with polyclonal gammopathy (3) . Here 
g/dL) and increased levels of serum IgG (4.4 g/L), which was approximately 2.0 g/L in March 2007. Total cholesterol was low (86 mg/dL). There was no M-peak in the protein fraction and no M-protein in the immunoelectrophoresis, although immune-fixation electrophoresis was not ex-
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